# The Macerich Company (MAC) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $23.24, market value $6.9 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). The Macerich Company reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 6.8×**. Each dollar of revenue is priced at 6.8×.
- **Price / book: 2.3×**. The shares trade at 2.3× book value; book value is a meaningful part of the valuation.

## Profitability
- **Net margin: -19.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -8.1%**. Return on equity is negative because earnings are negative.
- **Return on assets: -2.0%**. Each dollar of assets produces -2.0% of profit.

## Growth
- **Revenue growth (1 yr): 10.4%** (3-yr 5.7%/yr, 5-yr 5.2%/yr). Revenue grew 10.4% over the last year, against 5.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 11.4%**. Earnings per share rose 11.4%, roughly in step with revenue.

## Financial health
- **Debt to equity: 2.07**. Debt is 2.07 times equity, a leveraged balance sheet, which is normal for real estate.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 2.93%** ($0.68 per share, trailing). The Macerich Company yields 2.93%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 4**. 4 straight years of increases.
- **Dividend growth (5 yr): -10.0%/yr** (1-yr 0.0%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (16 analysts). 16 analysts cover The Macerich Company; the consensus is buy, with an average price target of $27.06 (+16% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 30.0%** (YTD 27.9%, 3-mo -1.1%). The shares are up 30.0% over twelve months including dividends.
- **From 52-week high: -12.9%** (45.0% above the low). Trading 13% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 34**. An RSI of 34 is neutral.
- **Beta (1 yr): 0.77** (volatility 30%). Beta of 0.77 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MAC · Page: https://foliofundamentals.com/stocks/mac

Not investment advice.